India Oncology Therapeutics Market Analysis

India Oncology Therapeutics Market Analysis

$ 3999

By 2030, it is anticipated that the India Oncology Therapeutics Market will reach a value of $7.8 Bn from $3.3 Bn in 2022, growing at a CAGR of 11.4% during 2022-2030. The Oncology Therapeutics Market in India is dominated by a few domestic pharmaceutical companies such as Cipla, Cadila Medical care, and Dr. Reddy's Research facilities. The Oncology Therapeutics Market in India is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for India Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.

ID: IN10INPH042 CATEGORY: Pharmaceuticals GEOGRAPHY: India AUTHOR: Dr. Vishwa Modhia

Buy Now

India Oncology Therapeutics Market Analysis Summary

By 2030, it is anticipated that the India Oncology Therapeutics Market will reach a value of $7.8 Bn from $3.3 Bn in 2022, growing at a CAGR of 11.4% during 2022-2030.

India is a lower middle-income, developing country located in Southern Asia bordering the Arabian Sea and the Bay of Bengal. The public health burden of cancer in India is constantly increasing, with 1.4 Mn new instances of cancer expected in 2020. The estimated number of cancer patients in India was 2.7 Mn (2020). In India, between 60% and 75% of cancer patients are treated in private hospitals, where they face high OOP expenses and troubled finance. By 2025, India's cancer burden is expected to exceed 1.5 Mn cases. The "Health Minister's Cancer Patient Fund (HMCPF)" inside the Rashtriya Arogya Nidhi (RAN) has also been formed to provide financial assistance to cancer sufferers. In metropolitan regions, the average medical expense per hospitalisation case for cancer treatment was 68,259 dollars.

A study by the Parliamentary Standing Committee highlighted concern about the inaccessibility and rising cost of cancer treatment. Cancers of the mouth cavity, stomach, and lungs account for more than 25% of cancer fatalities in men, while cancers of the uterine cervix, breast, and oral cavity account for 25% of cancer deaths in women. India's government spent 3 % of its GDP on healthcare in 2020.

India Oncology Therapeutics Market Analysis

Market Dynamics

Market Growth Drivers

Tobacco products are used by around 28.6 % of the Indian population, accounting for 267 Mn tobacco users in the country. Tobacco use has a significant impact on health in India, notably cancer. To assist suffering patients in affording medical care, the National Pharmaceutical Pricing Authority (NPPA) used exceptional powers in the public interest to start a Pilot on Trade Margin Rationalization for 42 anti-cancer medications. The National Programme for the Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke (NPCDCS) is being implemented at the district level by the National Health Mission (NHM). These aspects could boost India's Oncology Therapeutics Market.

Market Restraints

Treatment in the private sector is too expensive for low- and middle-income patients. The required radiation equipment for a developing country, according to WHO criteria, is 1380, compared to the current 686, which is insufficient to service over half of India's population. India has only 514 radiation facilities, according to the most recent statistics from the Atomic Energy Regulatory Board. Despite having one-fifth of the world's population, India is barely represented in 1.5 % of global clinical trials. The 2018 Ayushman Bharat insurance policy does not cover full prescriptions, the most recent cancer medicines, or numerous diagnostic tests. These factors may deter new entrants into the India Oncology Therapeutics Market.

Competitive Landscape

Key Players

  • Biocon: Biocon is an Indian biopharmaceutical organization that creates and delivers a scope of disease therapeutics, including biosimilars, monoclonal antibodies, and little particles. The organization has a few imaginative disease sedates that are as of now in clinical turn of events
  • Dr. Reddy's Research facilities: Dr. Reddy's Research facilities is an Indian global drug organization that creates and delivers a scope of malignant growth therapeutics, including chemotherapy drugs, designated treatments, and biosimilars. The organization has a few oncology medicates that are as of now in clinical turn of events
  • Cipla: Cipla is an Indian global drug organization that creates a scope of malignant growth therapeutics, including chemotherapy sedates and designated treatments. The organization has a few imaginative oncology medicates that are right now in clinical turn of events
  • Cadila Medical care: Cadila Medical care is an Indian drug organization that spotlights the turn of events and creation of a scope of malignant growth therapeutics, including chemotherapy sedates and designated treatments

Notable Recent Deals

January 2023: Sun Pharmaceutical Industries Ltd. said on Wednesday that one of its wholly-owned subsidiaries has released Palbociclib, a breakthrough anti-cancer medicine, in India for patients with advanced breast cancer. Palenotm (Palbociclib) 75 mg, 100 mg, and 125 mg will be offered from the pharmaceutical giant. Sun Pharma is launching Palbociclib at a low cost, which will aid in patient access. Palenotm will provide treatment to a number of advanced breast cancer patients in India.

November 2022: Biocon Biologics, Biocon's biosimilars manufacturing subsidiary, has finalised the acquisition of Viatris. The acquisition is anticipated to increase cancer therapy by giving it full ownership of its cooperation assets, which include the anti-cancer drugs Bevacizumab, Trastuzumab, Pertuzumab, and Pegfilgrastim, which is used to treat low white blood cells.

Healthcare Policies and Reimbursement Scenarios

In India, the administrative power liable for the endorsement and guideline of helpful items, including malignant growth therapeutics, is the Central Drugs Standard Control Organization (CDSCO). In expansion, India has laid out a public health care coverage framework that gives repayment to a scope of clinical costs, including the expense of disease therapeutics. The health care coverage framework is planned to guarantee that all residents approach important clinical considerations, no matter what their capacity to pay. India has carried out an exceptional program called the "National List of Essential Medicine" (NLEM), which is a rundown of meds that are considered fundamental. Also, some lung cancer medications may be made available through specific programmes within the Indian healthcare system, such as the National Health Protection Scheme (Ayushman Bharat).

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Oncology Therapeutics Segmentation

By Application (Revenue, USD Billion):

  • Blood Cancer
  • ?Colorectal Cancer
  • Gastrointestinal Cancer
  • Gynaecologic Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • ?Others

By Drugs (Revenue, USD Billion):

  • Revlimid
  • Avastin
  • Herceptin
  • Rituxan
  • Opdivo
  • Gleevec
  • Velcade
  • Imbruvica
  • Ibrance
  • Zytiga
  • Alimta
  • Xtandi
  • Tarceva
  • Perjeta
  • Temodar
  • Others

By Therapy (Revenue, USD Billion):

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy
  • Hormonal Therapy
  • Others

By Route of Administration (Revenue, USD Billion):

  • Oral
  • Parenteral
  • Others

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • ?Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 03 April 2023
Updated by: Shivam Zalke

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter